According to a Government impact assessment, seen by the Mail, creating a new quango to run the railways and a passenger ...

Investing.com -- Sarepta Therapeutics (NASDAQ:SRPT) stock rose 7% after the U.S. Food and Drug Administration approved new labeling for its gene therapy Elevidys that includes a Boxed Warning and ...

Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~ ~ Further Program Advancement Supported by ...